Skip to main content
TipRanks
Go Ultimate75% OFF

Jazz Pharmaceuticals (J7Z) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

J7Z Analyst Ratings

Strong Buy
17Ratings
16Buy1Hold0Sell
Based on 17 analysts giving stock ratings to Jazz Pharmaceuticals in the past 3 months

J7Z Stock 12 Month Forecast

CHF253.86â–²(0.00% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Jazz Pharmaceuticals in the last 3 months. The average price target is CHF 253.86 with a high forecast of CHF 282.79 and a low forecast of CHF 192.16. The average price target represents a ― change from the last price of ―.
Highest Price TargetCHF282.79Average Price TargetCHF253.86Lowest Price TargetCHF192.16

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:J7Z
Price TargetArticle
NeedhamCHF260.13→CHF258.45buy―Reiterated11/16/26
Morgan StanleyCHF267.68→CHF271.88buy―Reiterated11/13/26
UBSCHF273.56buy―Reiterated11/13/26
Piper SandlerCHF260.13→CHF276.91buy―Reiterated11/12/26
BarclaysCHF227.41→CHF230.76buy―Reiterated11/03/26
Wells FargoCHF251.74buy―Assigned11/03/26
Canaccord GenuityCHF251.74buy―Reiterated11/03/26
RBC CapitalCHF248.38→CHF255.94buy―Reiterated11/03/26
J.P. MorganCHF251.74→CHF260.13buy―Assigned11/03/26
Stifel NicolausCHF230.76buy―Reiterated11/03/26
TD CowenCHF251.74buy―Reiterated11/03/26
CitiCHF272.72buy―Reiterated11/02/26
Bank of America SecuritiesCHF262.65buy―Reiterated11/02/26
Truist FinancialCHF235.80→CHF239.99buy―Reiterated10/07/26
BernsteinCHF192.16hold―Reiterated09/25/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PALIPalisade Bio
RZLTRezolute
MDWDMediwound
OVIDOvid Therapeutics
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Jazz Pharmaceuticals

3 Months
Joseph Thome
Joseph ThomeTD Cowen
Success Rate14/22 ratings generated profit
64%
Average Return
+6.64%

Copying Joseph Thome's trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +6.64% per trade.

1 Year
Joseph Thome
Joseph ThomeTD Cowen
Success Rate20/22 ratings generated profit
91%
Average Return
+37.70%

Copying Joseph Thome's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +37.70% per trade.

2 Years
Joseph Thome
Joseph ThomeTD Cowen
Success Rate21/22 ratings generated profit
95%
Average Return
+65.85%

Copying Joseph Thome's trades and holding each position for 2 Years would result in 95.45% of your transactions generating a profit, with an average return of +65.85% per trade.

J7Z Analyst Recommendation Trends

020406080Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for J7Z
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00034
Buy3554504828
Hold42111
Sell00000
Strong Sell00000
total3956515233

In the current month, J7Z has received 32 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. J7Z average Analyst price target in the past 3 months is 253.86.

J7Z Financial Forecast

CHF-5CHF-1CHF3CHF7CHF11Q1 2026Q3 2026Q4 2026
HighCHF10.71
ConsensusCHF5.87
LowCHF4.47

J7Z Earnings Forecast

Next quarter’s earnings estimate for J7Z is CHF 5.87 with a range of CHF 4.47 to CHF 10.71. The previous quarter’s EPS was -CHF 3.27. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF901.8MCHF955.4MCHF1BCHF1.1BCHF1.1BQ1 2026Q3 2026Q4 2026
HighCHF1.12B
ConsensusCHF1.08B
LowCHF1.06B

J7Z Sales Forecast

Next quarter’s sales forecast for J7Z is CHF 1.08B with a range of CHF 1.06B to CHF 1.12B. The previous quarter’s sales results were CHF 1.05B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

J7Z Stock Forecast FAQ

What is CH:J7Z’s average 12-month price target, according to analysts?
Based on analyst ratings, Jazz Pharmaceuticals’s 12-month average price target is CHF253.86.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Jazz Pharmaceuticals a Buy, Sell or Hold?
Jazz Pharmaceuticals has a consensus rating of Strong Buy, which is based on 16 buy ratings, 1 hold ratings and 0 sell ratings.
What is Jazz Pharmaceuticals’s share price target?
The average share price target for Jazz Pharmaceuticals is CHF253.86. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF282.79, and the lowest forecast is CHF192.16. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about Jazz Pharmaceuticals?
Jazz Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Jazz Pharmaceuticals?
To buy shares of CH:J7Z, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.